🟢 Milestone Pharmaceuticals is trading 6.2% up today on a rebound from post-earnings weakness

Milestone Pharmaceuticals is trading at $1.29 (6.2%) up today, rebounding after recent selling pressure tied to its Q1 earnings miss and CARDAMYST revenue disappointment.

• The move appears driven by improving broader market sentiment as major U.S. indices trade higher.
• With no new company-specific news or filings today, investors may be selectively bargain-hunting in beaten-down biotech names.
• The stock is recovering ground after prior weakness following the company's recent financial results.